A clinical-stage biopharmaceutical company translating genetic discoveries into new treatments for diseases with significant unmet medical need
arctictherapeutics.comLinkedInREYKJAVIK, IcelandBiotech
6 sources · checked 1 time, last 1h ago
4 sources
No headquarters or valuation is stated. Reykjavik and Philadelphia appear in the dateline, not as headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $21.5M | 2026-10-21 | Pekron, Sanos Group, Kaldbakur, Landvættir | 4 outlets. #56 in Trending |
6 sources · checked 1 time, last 1h ago [ VERIFIED ] read against 1 of 6 sources | ||||
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $27.7M €26.5 million | 2025-01-22 | not stated | No recent discussion |
4 sources [ VERIFIED · CORRECTED ] read against 1 of 4 sources
No headquarters or valuation is stated. Reykjavik and Philadelphia appear in the dateline, not as headquarters. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]4 pages read: arctictherapeutics.com, prnewswire.com, globalgenes.org·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 4 sources·[ BRANDING ]logo and colour from the homepage | ||||